Le Lézard
Classified in: Environment, Health, Business
Subjects: LIC, CXP

YUMI announces nationwide Walmart launch, as retail footprint rapidly expands


LOS ANGELES, May 6, 2024 /PRNewswire/ -- YUMI, the leading provider of nutritious kid snacks, proudly announces the availability of its best-selling products at Walmart, the largest retailer in the United States. This collaboration marks a significant milestone in YUMI's mission to revolutionize children's nutrition by making healthy, organic options accessible.

"We're thrilled to partner with Walmart to bring YUMI to even more families," said Angela Sutherland, co-CEO and co-founder. "Our commitment to crafting delicious and nutritious snacks has resonated with parents since day one, and we're excited to make our organic bars and puffs easily accessible to Walmart families. By joining forces with Walmart, we can help more parents and caregivers make healthier choices for their children."

Since its retail launch in 2022, YUMI's nutrient-dense bars and puffs have quickly become household favorites, setting new standards in nutrition, taste, and quality. YUMI's bestselling bars are made with real, organic ingredients and feature at least eight superfood vegetables in every bar. Each bar is mapped against the most common nutrient deficiencies among kids in the United States, featuring key micronutrients, such as iron, vitamin D, and Zinc.

All of YUMI's bars and rice-free puffs are certified organic, certified clean and designed to be daycare and school-friendly, with recipes that are gluten-free, dairy-free, and peanut-free. As a proud member of the Clean Label Project, YUMI's baby and toddler products are tested for more than 400 potential contaminants, including heavy metals.

"We are incredibly proud of the journey that has brought us to this moment," says Evelyn Rusli, co-CEO, co-founder. "We remain steadfast in our commitment to raise a healthier generation, with products that support every stage of development. This significant expansion into Walmart reflects the seismic shift happening in this country, as more families demand nutritious options."

For more information about YUMI and its range of nutritious baby food products, please visit www.helloyumi.com

ABOUT YUMI

Since its national launch in 2019, YUMI has been on a mission to improve the health of future generations through transparent, science-backed nutritional products. Leveraging data and food science, YUMI empowers its community to make informed decisions about their children's nutrition, redefining what it means to be a modern American food company. Their products are organic, vegan, gluten-free, non-GMO, and kosher, and certified by the Clean Label Project.

SOURCE YUMI


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: